As shown in the graph in Figure 4, only 5/9 (56%) mice developed tumors when injected with HNSCC cells that exhibited stable suppression of ADAM17, whereas 5/7 (71%) mice developed tumors when injected with HNSCC cells derived from control transduced cells expressing normal levels of ADAM17. Here, ADAM17 is linked to head and neck squamous cell carcinoma.